Ginsenoside Rh4 inhibits inflammation-related hepatocellular carcinoma progression by targeting HDAC4/IL-6/STAT3 signaling

This study aimed to investigate the effects of Ginsenoside Rh4 (Rh4) on inflammation-related hepatocellular carcinoma (HCC) progression and the underlying mechanism. HCC cells (HUH7 and LM3) were induced by lipopolysaccharide (LPS) to establish an inflammatory environment in the absence or presence...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Ruiyuan, Luo, Shujuan, Zhang, Meng, Wang, Wei, Zhuo, Shaoyuan, Wu, Yajing, Qiu, Qingmei, Yuan, Yuan, Jiang, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657317/
https://www.ncbi.nlm.nih.gov/pubmed/37843550
http://dx.doi.org/10.1007/s00438-023-02070-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657317/
https://www.ncbi.nlm.nih.gov/pubmed/37843550
http://dx.doi.org/10.1007/s00438-023-02070-w

Ejemplares similares